SRPRA affects hyperoxia-induced bronchopulmonary dysplasia by modulating endoplasmic reticulum stress through the

Yanlin Tan1, Shisi Xiong1, Wenchang Ni1

  • 1Department of Pediatrics, Wuhan Third Hospital, No. 216 Guanshan Avenue, Hongshan District, 430000, Wuhan, China.

Insights

Reducing SRPRA levels protects against lung injury in premature infants by decreasing endoplasmic reticulum (ER) stress. This finding highlights SRPRA as a potential therapeutic target for bronchopulmonary dysplasia (BPD).

Area of Science:

  • Cell Biology
  • Pulmonology
  • Molecular Biology

Background:

  • Bronchopulmonary dysplasia (BPD) is a chronic lung disease in preterm infants, often caused by hyperoxia-induced alveolar epithelial cell injury.
  • Excessive endoplasmic reticulum (ER) stress is a key factor in BPD progression.
  • The role of SRPRA, upregulated in BPD, in ER stress and disease mechanisms is unclear.

Purpose of the Study:

  • To investigate the role of SRPRA in hyperoxia-induced BPD.
  • To elucidate the underlying mechanisms connecting SRPRA, ER stress, and BPD pathogenesis.

Main Methods:

  • Established a hyperoxia-exposed alveolar type II epithelial cell (AECII) model in vitro.
  • Assessed cell viability, proliferation, apoptosis, inflammation, and oxidative stress.
  • Quantified SRPRA, apoptosis, inflammation, and ER stress (CHOP pathway) markers using qRT-PCR and Western blotting.

Main Results:

  • SRPRA was upregulated in hyperoxia-induced AECIIs.
  • Hyperoxia impaired AECII viability and increased apoptosis, inflammation, and oxidative stress.
  • SRPRA knockdown mitigated hyperoxia-induced damage and inflammation by downregulating CHOP-mediated ER stress.

Conclusions:

  • SRPRA knockdown protects against hyperoxia-induced AECII injury by reducing CHOP-mediated ER stress.
  • SRPRA plays a pathogenic role in BPD and represents a potential therapeutic target.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Physiological Control of Respiration01:23

Physiological Control of Respiration

Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.